JLE

Epileptic Disorders

MENU

Clinical experience with levetiracetam in idiopathic generalized epilepsy according to different syndrome subtypes Volume 7, issue 3, September 2005

Betts et al, 2000 Betts T, Waegemans T, Crawford P. A multicenter, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2,000mg daily and 4,000mg daily, without titration in patients with refractory epilepsy. Seizure 2000; 9: 80-7.

Cohen, 2003 Cohen J. Levetiracetam monotherapy for primary generalised epilepsy. Seizure 2003; 12: 150-3.

Commission, 1989 Commission on Classification and terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989; 30: 389-99.

Gallagher et al, 2004 Gallagher MJ, Eisenman LN, Brown KM, et al. Levetiracetam reduces spike-wave density and duration during continuous EEG monitoring in patients with idiopathic generalized epilepsy. Epilepsia 2004; 45: 90-1.

Greenhill et al, 2002 Greenhill L, Betts T, Yarrow H. Effect of levetiracetam on resistant juvenile myoclonic epilepsy. Seizure 2002; 11: 531.

Krauss et al, 2001 Krauss GL, Abou-Khalil B, Sheth SG, et al. Efficacy of levetiracetam for treatment of drug-resistant generalized epilepsy. Epilepsia 2001; 42(Suppl 7): 181; [abstract].

Krauss et al, 2003 Krauss GL, Betts T, Abou-Khalil B, Bergey G, Yarrow H, Miller A. Levetiracetam treatment of idiopathic generalized epilepsy. Seizure 2003; 12: 617-20.

Kasteleijn-Nolst Trenité et Hirsch, 2003 Kasteleijn-Nolst Trenité DGA, Hirsch E. Levetiracetam: preliminary efficacy in generalized seizures. Epileptic Disord 2003; 5(Suppl 1): S39-S44.

Kasteleijn-Nolst Trenité et al, 1996 Kasteleijn-Nolst Trenité DGA, Marescaux C, Stodieck S, Edelbroek PM, Oosting J. Photosensitive epilepsy: a model to study the effects of antiepileptic drugs. Evaluation of the piracetam analogue, levetiracetam. Epilepsy Res 1996; 25: 225-30.

Kumar et Smith, 2004 Kumar SP, Smith PE. Levetiracetam as add-on therapy in generalised epilepsies. Seizure 2004; 13(7): 475-7.

Panayiotopoulos, 1997 Panayiotopoulos CP. Absence epilepsies. In: Engel Jr. J, Pedley TA, eds. Epilepsy: A Comprehensive Textbook. Philadelphia: Lippincott-Raven, 1997: 2327-46.

Smith et al, 2000 Smith K, Betts T, Pritchett L. Levetiracetam, a promising option for treatment of juvenile myoclonic epilepsy. Epilepsia 2000; 41(Suppl): 39.

Weber et Beran, 2004 Weber S, Beran RGJ. A pilot study of compassionate use of Levetiracetam in patients with generalised epilepsy. Clin Neurosci 2004; 11(7): 728-31.